Familial or early-onset AD, which represents less than 5% of all cases, is primarily associated with mutations in genes such as amyloid precursor protein (APP) and presenilin 1 and 2 (PSEN1 and PSEN2). This evidence concerns the gene APP and Alzheimer disease.